In this study, we have developed QSAR models for a series of 38 piperidine-4-carboxamide CCR5 antagonists using CoMFA, CoMSIA and HQSAR methods. Developed models showed good statistics in terms of q 2 and r 2 values. Best predictions obtained with standard CoMFA model (r 2 = 0.888, q 2 = 0.651) and combined CoMSIA model (r 2 = 0.892, q 2 = 0.665) with electrostatics and H-bond acceptor parameter. The validity of developed models was assessed by test set of 9 compounds, which showed good predictive correlation coefficient for CoMFA (0.804) and CoMSIA (0.844). Bootstrapped analysis showed statistically significant and robust CoMFA (0.968) and CoMSIA (0.936) models. Best HQSAR model was obtained with a q 2 of 0.662 and r 2 of 0.936 using atom, connection, hydrogen, donor and acceptor as parameters and fragment size (7-10) with optimum number of 6 components. Predictive power of developed HQSAR model was proved by test set and it was found to be 0.728.
Introduction
Human Immunodeficiency Virus type-1 (HIV-1) infection, which eventually leads to the acquired immunodeficiency syndrome (AIDS), was first discovered by Barrae et al in 1983 . 1 At present, AIDS remains to be a lethal disease threatening human's health especially sub-Saharan Africa and Southeast Asia. The chemokine receptor CCR5 has proven to be an exciting target for pharmaceutical industry in the HIV-1 and inflammation therapeutic areas. This fact inspired a great amount of research in last decade to identify anti HIV-1 therapeutic by targeting the CCR5 mediated entry mechanism. This effort recently resulted in FDA approval for small molecular inhibitor, Maraviroc (Selzentry) for the treatment of HIV-1 infection. 2 HIV primarily infects vital cells in the human immune system such as helper T-cells (specifically CD4+ T-cells), macrophages and dendrite cells. [3] [4] [5] HIV enters into these cells by adsorption of viral glycoprotein to receptors on the target cell. This step is followed by the fusion of viral envelope with the cell membrane and release of the HIV capsid into the cell. [6] [7] HIV infection leads to low levels of CD4+ T-cells through three main mechanisms: Firstly, direct viral killing of infected cells; secondly, increased rates of apoptosis in infected cells; and thirdly, killing of infected CD4+ T-cells by CD8 cytotoxic lymphocytes that recognize infected cells. CCR5 receptor is a member of G-Protein coupled receptors (GPCR) superfamily. 8, 9 It has been identified as a primary co-receptor on CD4+ cells for entry of macrophage-tropic (M-tropic or R5) HIV-1 isolates. 10 Few natural ligands (MIP-1a, MIP-1b and RANTES) have been identified for CCR5. 11 Currently, there is an only few small molecular inhibitors are being investigated as anti-HIV-1 agents in human clinical trials [12] [13] [14] [15] [16] [17] and shown in Figure 1 . To date, only one drug Maraviroc (Selzentry) was approved by FDA on August 6 th 2007. Still, they raised concerns that it may be associated with serious complications such as liver damage, lymphoma, infections and heart attack.
Literature survey showed that previously 3D-QSAR and virtual screening studies of CCR5 antagonists 1-(3,3-diphenyl- 18, 19 They shows that for high affinity binders key chemical and structural requirement can be identified using physicochemical parameter, topological property and 3D field such as steric, electrostatics, hydrophobic, hydrogen bond donor/acceptor around a set of aligned ligand molecules. 3D-QSAR models, CoMFA and CoMSIA on a series of piperidine-based CCR5 antagonists have been developed by Song et al. 20 Whereas, Y. Zhuo et al performed 3D-QSAR study for 1,3,4-trisubstituted pyrrolidine based CCR5 inhibitors. 21 An excellent work docking and 3D-QSAR study on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes derivatives was done by Xu et al., 22 where they developed homology model for CCR5, and docking based conformations of all molecules were used for 3D-QSAR model generation.
There has been need for developing newer, selective and potent inhibitors of CCR5. A successful 3D-QSAR model not only helps in better understanding of structure activity relationship data for any class of compounds, but also ensure researcher an in depth analysis of lead compounds in further studies. Here, we have chosen a series of piperidine-4-carboxamide derivatives containing potent and selective CCR5 functional antagonists. 23 Hence, we started CoMFA, 24 CoMSIA 25 and HQSAR 26 studies as validation tools for QSAR analysis of CCR5 inhibitors. CoMFA and CoMSIA are the methods which are used in rational drug design. To develop novel antagonistic agents with high potency and selectivity, detailed information is required about structural features influencing biological activity towards CCR5 receptor. Since the crystal structure of CCR5 or its complex with any ligand is not available, the interactions between the CCR5 receptor and its antagonists are not known. Correlation between the structural properties of compounds with their biological activities is believed to gain an insight into the interaction mechanisms of CCR5 to antagonists. This could provide useful information for designing novel anti-HIV-1 drugs. CoMFA and CoMSIA analyses involve alignment of molecules in a structurally and pharmacologically reasonable manner on the basis of assumption that each molecule acts via common macromolecular target binding site. Since there is no experimental structure was reported, HQSAR analysis was also done which does not require-3D structure, bioactive conformation and molecular alignment. It generates QSAR equation by molecular fragments fingerprints as independent variable and biological activity as dependent variable.
Computational Details
Dataset. Dataset used in this study comprised of piperidine-4-carboxamide derivatives reported as potent CCR5 inhibitors by Imamura et al. 23 The binding affinities of given antiretroviral concentration in nano-molar (nM) range were converted to the molar (M) concentration and then converted to logarithmic scale for further analyses on dataset, using the following formula.
pIC 50 = -log IC 50 Where, IC50 is concentration of antagonist to provide 50% inhibition of CCR5 receptor. Consequently we used 38 piperidine-4-carboxamide derivatives with their activities (Table 1-4) to establish QSAR models. Total dataset was divided randomly into a training set of 29 compounds and test set (wide range of activity) of 9 compounds. Molecular modeling. All computational studies were performed using molecular modeling package SYBYL 8.1 27 installed on a Linux system. Since crystal structure of CCR5 with any ligand is not available, the most active molecule 5h (IC50 = 0.29 nM, pIC50 = 9.53) was considered as a template molecule and random search method was carried out to obtain least energy conformation. Least energy conformation was considered as a bioactive conformation and then minimized it by applying Tripos force field with Powell method and conjugate gradient minimizer. The minimization was terminated when the energy gradient convergence criterion of 0.05 kcal/mol was reached or when the 5000 step minimization cycle was exceeded. Rests of the molecules were built by changing required substitution on the template molecule and minimized similarly as template molecule by keeping core part constrained. Finally GasteigerHückel charges were applied to all the molecules of dataset and it was subsequently used for QSAR studies. Structural alignment. Molecular alignment is one of the most important and sensitive parameter in 3D-QSAR. Least energy conformation of template molecule (5h) was considered as a bioactive conformation and other molecules of the dataset were aligned on it. Atom fit method was used to align all molecules of dataset and shown in Figure 2 .
CoMFA and CoMSIA interaction energy. For the alignment set, the steric and electrostatic CoMFA field was calculated at each lattice intersection of a regularly spaced grid of 2.0 Ǻ unit. The grid box dimensions were determined automatically in such a way that the region boundaries were extended beyond 4.0 Å in each direction from the co-ordinates of each molecule. The steric and electrostatic interactions between probe and remaining molecules were calculated. The generated steric and electrostatic fields were scaled by CoMFA_STD scaling method in SYBYL with default energy of +30 kcal/mol. The electrostatic interactions are modeled by Columbic potential and van der Waals interaction using Lennard-Jones potential respectively, and calculated by using standard Tripos force field. The distance dependent dielectric constant 1.00 was used. A sp 3 hybridized carbon atom having +1 charge serves as a probe for calculating steric and electrostatic field. Any singularities were avoided at atomic position in CoMSIA field because a Gaussian type distance dependence of physicochemical properties was adopted; thus no arbitrary cutoff was required. Similarly indices were calculated as 0.3 as attenuation factor (α) for Gaussian type distance.
RF CoMFA. Region focusing is an application of weights to the lattice point in a CoMFA region to enhance or to attenuate the contribution of points to subsequent analysis. When the weights are StdDev*Coefficient values, the process is exactly equivalent to image enhancement of the derived CoMFA maps. The sharpness of focusing is controlled by a user provided exponential factor.
HQSAR. Hologram QSAR (HQSAR) is a technique which employs fragment fingerprints as predictive variables of biological activity or other structural related data. 26 HQSAR doesn't require 3D structure of bioactive conformation or molecular alignments. HQSAR model generation deals with the 2D structure directed fragment fingerprints. 28 These molecular fingerprints are broken into strings at fixed intervals as specified by a hologram length (HL) parameter. The hologram length determines the number of bins in the hologram into which the fragments are hashed. Each corresponding fragment SYBYL line notation (SLN) is then mapped to a pseudo-random integer in the range (50 -500) using cyclic redundancy check (CRC) algorithm. The integer generated by the CRC algorithm is unique and reproducible for each and every unique SLN string. The hashing then occurs by folding the pseudorandom integer for a particular SLN string into the bin range defined. In HQSAR, bins contain PLS analysis. The regression analysis was carried out by using partial least square (PLS) method [29] [30] [31] in CoMFA and CoMSIA. The cross-validation analysis was performed using leave-one-out (LOO) method, wherein one compound was removed from the dataset and its activity was predicted using the model derived from the rest of the molecules. To speed up analysis and to reduce the noise, the column with values (σ) below 2.0 kcal/mol was filtered off. Subsequently, PLS analyses were performed without cross validation, using optimum number of components (ONC) obtained from LOO method. The q 2 that resulted in optimum number of components and lowest standard error of prediction (SEP) were considered for further analyses and calculated using following formula: where, γpred, γactual and γmean are predicted, actual, and mean values of the target property (pIC50) respectively. Equal weights for CoMFA were assigned to steric and electrostatic fields using CoMFA_STD scaling option. To derive 3D-QSAR models CoMFA and CoMSIA descriptors were used as an independent variable and pIC50 activity value as dependent variable. To further assess the robustness and statistical confidence of the models, bootstrapping analysis for 1000 runs was performed.
Predictive correlation coefficient (r 2 pred ). The predictive ability of generated QSAR models were determined by using a test set of 9 compounds that were excluded during model generation. The energy minimization and geometry optimization of these 9 molecules is as same as the training set compounds described above, and their activity was predicted by using the model generated from training set. The predictive correlation coefficient (r 2 pred), based on test set molecules is computed by using following formula.
Where, SD is sum of squared deviation between the biological activity of test set molecules and mean activity of training set molecules. PRESS is predictive residual sum of square and is calculated by taking difference in predicted and actual activity of test set molecules. For all conventional analysis (non cross validation) the 'minimum sigma' standard deviation threshold was set to 2.0 kcal/mol.
Results and Discussions
CoMFA and CoMSIA analysis. We derived 3D-QSAR Co-MFA and CoMSIA models for piperidine-4-carboxamide derivatives with good predictivity in terms of q 2 respectively. The field contribution value for CoMFA indicates that both steric and electrostatic field contributes almost similar for the model development. But, in case of CoMSIA the electrostatic field has more impact than H-bond acceptor field and it is resulted in higher q 2 value. The regression analysis for both CoMFA and CoMSIA models were given in Table 5 . Actual and predicted values along with residual values for CoMFA and CoMSIA training set and test set molecules were summarized in Table 6 .
HQSAR analysis. HQSAR model generation was carried out using several parameters such as fragment distinction, fragment size and best hologram length (BHL). The HQSAR models were generated using default fragment size (4-7) combined with various hologram length and fragment types. The final model chosen for HQSAR analysis is highlighted in bold font. used to predict biological activity of novel compounds. Predictive ability of CoMFA, CoMSIA and HQSAR models. The predictive ability of QSAR models was validated by a test set of 9 compounds, which were excluded during model generation. Both CoMFA and CoMSIA models showed good predictive power in terms of r 2 pred and, which is equal to 0.804 and 0.844, respectively. The graph of predicted versus actual activities for training set and test set of CoMFA and CoMSIA models are shown in Figure 3A and 3B. The developed HQSAR model shows good predictive power of 0.728. The detailed predicted versus actual activities along with residual values for training set and test set was depicted in Table 9 and plotted in Figure 4 .
Interpretation of contour maps. The different density maps of the steric, electrostatic and H-bond acceptor parameters of CoMFA and CoMSIA models are represented as 3D coefficient contour maps. The contour maps surround all lattice points where the QSAR is found to be strongly associate with changes in the molecular field values (which basically mean changes in structure) as well as in binding affinity or any other measure of biological property. According to the standard SYBYL settings, steric interactions are represented by green and yellow colored contours while electrostatic interactions are represented as red and blue contours. Green contours stand for points where the Lennard-Jones potential has to be increased by appropriate groups to increase the biological activity whereas the yellow contours are used to underline the points where such a potential has to be decreased by suitable substituent's to correlate with increased binding affinity. The electrostatic red color shows the regions where the presence of a negative charge is expected to enhance the activity, whereas the blue color indicates regions where placing more positive charge is expected to correlate with increased binding affinity. In case of H-bond acceptor field magenta color denotes where the presence of acceptor atom is expected to increase the activity, whereas red color indicates decrease in inhibitory activity. In CoMFA contour map template molecule (5h) was shown in background. 3D-CoMFA contour map for best fitted model with steric field for template (IC50 = 0.29 nM, pIC50 = 9.53) molecule was shown in Figure 5 . The presence of green colored contour on central phenyl ring near the meta and para position indicates that, this position is favorable for small bulky group like Cl and Me, and increases binding potency. In case of compound 5i (IC50 = 18 nM, pIC50 = 7.74) and 5j (IC50 = 30 nM, pIC50 = 7.52), the bulkier substitution at para position of central phenyl ring leads to decrease in binding affinity. The two yellow contours near para position indicate that, sterically bulkier groups (4-i-Pr and 4-MeO) are unfavorable for inhibitory activity. The alkyl linker plays a crucial role in demonstrating the inhibitory potency. It is clear that the increased or decreased in alkyl chain length in compound 14 (IC50 = 52 nM, pIC50 = 7.28) and in compound 18 (IC50 = 480 nM, pIC50 = 6.31) leads to reduced binding potency. Variation in alkyl chain length resulted in change in conformation of 4-benzylpiperidine moiety. It might be because of steric hindrance with receptor cavity which is indicated by the presence of yellow contours near 4-benzylpieridine moiety. At R 3 position introduction of -CF3 group in compound 11a (IC50 = 8.7 nM, pIC50 = 8.01) resulted in decrease in CCR5 binding potency, but introduction of more polar group like NO2 in compound 11b (IC 50 = 2.4 nM, pIC 50 = 8.62) retained the inhibitory potency. It suggests that polar groups are preferable at this position. The alkylsulfonyl (11f-11h) and aminosulfonyl (11i-11l) derivatives exhibit good activity, which indicate larger groups, had better effect on the activity (11h, k, and l).
CoMFA electrostatic contour map for template molecule (5h) is shown in Figure 6 . Blue contour near para position of CoMSIA electrostatics contour map ( Figure 7 ) shows blue and red polyhedra around template molecule. At R 1 position red contour near carbonyl group indicates this group is favorable for inhibitory activity. According to experimental study it is clear that, amide moiety is essential for CCR5 binding. The 1-acetylpiperidin-4-yl substituent afforded compound 7a (IC50 = 16 nM, pIC50 = 7.78) showed increased binding potency over compound 1 (IC50 = 480 nM, pIC50 = 6.31), because of presence of acetylpiperidinyl moiety. Here, amide group orientation plays a major role in CCR5 inhibition. Bulkier substitutions on 'N' of piperidine ring, increases the inhibitory potency when compared it with compound 1. Replacement of acetyl group on piperidine moiety resulted in substantial reduction in binding affinity, indicates amide carbonyl group is essential for binding affinity. In case of compound 6a (IC50 = 4300 nM, pIC50 = 5.37), lack of substitution on piperidine N, resulted in loss of potency. It indicates that for better inhibitory potency, piperidine 'N' must be substituted. The presence of electronegative substituent (R 3 = F) on 4-benzylpiperidine moiety had slightly better effect on inhibitory potency (5e vs. 5f, 5g vs. 5h). Figure 8 depict CoMSIA H-bond acceptor contour map. The template molecule was shown in background and surrounded by red and magenta colored contour. Small magenta contour occurs near R 1 (C = O) group. It indicates that carbonyl group acts as an H-bond acceptor. Big red colored contour occurs near methyl part of acetyl group indicates that position is unfavorable for H-bond acceptor group. Another small sized red contour occurs near R3 position indicates that corresponding position is unfavored for H-bond acceptor groups.
HQSAR atomic contribution map. HQSAR technique gives us straight forward clues about the individual atomic contribution to the biological activity through the different color codes. HQSAR color codes the individual atoms of molecules depending upon their contribution towards biological activity. Atomic contribution map for few molecules was depicted in Figure 9 . Highly active compound 5h (IC50 = 0.29 nM, pIC50 = 9.53) color coded with yellow, green-blue and white color indicates contributes positively for inhibitory activity. The carbonyl group of R 1 substitution shows yellow color code indicates that this group is contributing positively for inhibitory activity. This is well supported by CoMFA and CoMSIA electrostatic red contour map. The 4-Me substitution on central phenyl ring shows yellow color code for hydrogen indicate that contribute positively for activity. It is supported by CoMFA and CoMSIA steric and electrostatics green and blue contour maps. Another highly active compound 5l (IC 50 = 0.50 nM, pIC 50 = 9.30) of the series shows similar color coding system as like compound 5h. Both compounds show blue and yellow color code on piperidine ring of 4-benzylpiperidine moiety, it indicates positive contribution for inhibitory activity. The least active molecule of dataset 6a (IC50 = 4300 nM, pIC50 = 5.37) shows red, red-orange and orange color code for atomic contribution. The color code red on piperidine ring signifies that, because of lack of substitution at R 1 position this compound is not able to make essential amide bond, which is necessary for potent bioactivity. Unsubstituted 
Conclusion
This study was conducted to rationalize the CCR5 antagonistic activity of 38 piperidine-4-carboxamide derivatives by Co-MFA, CoMSIA and HQSAR analyses. All these generated models showed good statistical correlation in terms of q 2 and r 2 values and well explained the variance between biological activities. Additionally higher bootstrapped r 2 values and lowest standard error of estimate indicates the stability of QSAR models. The statistical significance and robustness of developed QSAR models were judged by test set prediction. Comparing the CoMFA and CoMSIA analyses results, we can see that the CoMSIA model has slightly better predictive ability than CoM-FA model. The spatial effect of steric, electrostatics and H-bond acceptor descriptors on biological activity of aligned molecules were given by contour map. We could suggest from contour map analysis that, incorporation of small electropositive group at para position of central phenyl ring could increase binding potency and it is supported by yellow color code in HQSAR contribution map. Contour map analysis revealed that compound with carbonyl or sulfonyl group at R 1 position is favorable for activity and supported by favorable yellow color code in HQSAR contribution map. At R 3 position polar substituents are favorable for retaining the inhibitory activity and larger substituent's had better effect on activity. The molecular modeling techniques are successfully employed in this study to correlate biological activities with structures. Good statistical correlation and satisfactory predictive power of developed models indicate that these models can serve as computational tools for rational design of novel CCR5 antagonists with enhanced activity and prediction prior to synthesis.
